Skip to main content

Michael Anthony Moody, MD

Associate Professor of Pediatrics
Associate Professor in the Department of Immunology
Member of the Duke Human Vaccine Institute
Campus mail: 2 Genome Ct, MSRB II Room 3007, Durham, NC 27710
Phone: (919) 668-2551
Email address: tony.moody@duke.edu

Tony Moody, MD is an Associate Professor in the Department of Pediatrics, Division of Infectious Diseases and the Department of Immunology at Duke University Medical Center. Dr. Moody is the Director of the Laboratory of B cell Immunotechnology at the Duke Human Vaccine Institute (DHVI). Research in the Moody lab is focused on understanding the B cell responses during the earliest stages of HIV infection. The lab has become a resource for human phenotyping, flow characterization, staining and analysis at DHVI.  Dr. Moody is also the Director of the CHAVI DHVI Repository that provides support for the collaborative work occurring at DHVI and with its many collaborators around the world by providing processing, shipping, and inventory support for a wide array of projects. Additionally, Dr. Moody serves as one of the Principal Investigators of the new Duke Collaborative Influenza Vaccine Innovation Centers (CIVICs) where he will conduct basic immunology and virology research to identify potential influenza vaccine candidates.

In addition, the Moody lab has active projects looking at the response to HIV-1, syphilis, and autoimmunity.

Education and Training

  • Fellowship, Pediatric Infectious Diseases, Pediatrics, Duke University, 2003 - 2006
  • Pediatric Chief Resident, Pediatrics, Emory University, 2002 - 2003
  • Pediatric Internship & Residency, Pediatrics, Emory University, 1999 - 2002
  • M.D., Duke University, 1999

Selected Grants and Awards

Publications

Lorimier, R. de, M. A. Moody, B. F. Haynes, and L. D. Spicer. “NMR-derived solution conformations of a hybrid synthetic peptide containing multiple epitopes of envelope protein gp120 from the RF strain of human immunodeficiency virus.” Biochemistry 33, no. 8 (March 1, 1994): 2055–62. https://doi.org/10.1021/bi00174a011.

Full Text

MYERS, D., M. A. MOODY, B. F. HAYNES, and L. D. SPICER. “THE 2-D NMR CHARACTERIZATION OF A 39 RESIDUE IMMUNOGENIC CHIMERIC PEPTIDE DERIVED FROM HIVMN.” Biophysical Journal 66, no. 2 (February 1, 1994): A29–A29.

Scholars@Duke

Liao, H. X., M. C. Levesque, K. Patton, B. Bergamo, D. Jones, M. A. Moody, M. J. Telen, and B. F. Haynes. “Regulation of human CD44H and CD44E isoform binding to hyaluronan by phorbol myristate acetate and anti-CD44 monoclonal and polyclonal antibodies.” J Immunol 151, no. 11 (December 1, 1993): 6490–99.

Scholars@Duke

HAYNES, B. F., J. V. TORRES, A. J. LANGLOIS, D. P. BOLOGNESI, M. B. GARDNER, T. J. PALKER, R. M. SCEARCE, et al. “INDUCTION OF BROADLY CROSS-REACTIVE HIV NEUTRALIZING ANTIBODIES IN PRIMATES USING A PRIME-BOOST REGIMEN OF HYBRID SYNTHETIC GP120 ENVELOPE PEPTIDES.” Aids Research and Human Retroviruses 9 (October 1, 1993): S29–S29.

Scholars@Duke

Haynes, B. F., J. V. Torres, A. J. Langlois, D. P. Bolognesi, M. B. Gardner, T. J. Palker, R. M. Scearce, D. M. Jones, M. A. Moody, and C. McDanal. “Induction of HIVMN neutralizing antibodies in primates using a prime-boost regimen of hybrid synthetic gp120 envelope peptides.” J Immunol 151, no. 3 (August 1, 1993): 1646–53.

Scholars@Duke

LIAO, H. X., M. C. LEVESQUE, K. PATTON, B. BERGAMO, D. JONES, M. A. MOODY, and B. F. HAYNES. “REGULATION OF HUMAN CD44H AND CD44E ISOFORM BINDING TO HYALLURONAN BY PHORBOL-MYRISTATE ACETATE AND ANTI-CD44 MONOCLONAL AND POLYCLONAL ANTIBODIES.” Clinical Research 41, no. 2 (April 1, 1993): A169–A169.

Scholars@Duke

HAYNES, B. F., Y. YASUTOMI, J. V. TORRES, M. B. GARDNER, A. J. LANGLOIS, D. P. BOLOGNESI, T. J. MATTHEWS, et al. “USE OF SYNTHETIC PEPTIDES IN PRIMATES TO INDUCE HIGH-TITERED NEUTRALIZING ANTIBODIES AND MHC CLASS I-RESTRICTED CYTOTOXIC T-CELLS AGAINST AIDS RETROVIRUSES - AN HLA-BASED VACCINE STRATEGY.” Clinical Research 41, no. 2 (April 1, 1993): A261–A261.

Scholars@Duke

Haynes, B. F., Y. Yasutomi, J. V. Torres, M. B. Gardner, A. J. Langlios, D. P. Bolognesi, T. J. Matthews, R. M. Scearce, D. M. Jones, and M. A. Moody. “Use of synthetic peptides in primates to induce high-titered neutralizing antibodies and MHC class I-restricted cytotoxic T cells against acquired immunodeficiency syndrome retroviruses: an HLA-based vaccine strategy.” Trans Assoc Am Physicians 106 (1993): 33–41.

Scholars@Duke

Seltzman, H. H., M. A. Moody, and M. K. Begum. “Allylic substitution/rearrangement of cannabinoids with trimethylsilyl bromide.” Tetrahedron Letters 33, no. 24 (June 9, 1992): 3443–46. https://doi.org/10.1016/S0040-4039(00)92658-3.

Full Text

ANTHONY, D. C., V. AMARNATH, G. R. SIMONS, M. B. STCLAIR, M. A. MOODY, and D. G. GRAHAM. “ACCUMULATION OF PYRROLE RESIDUES AS THE MOLECULAR-BASIS OF CUMULATIVE NEUROTOXIC DOSE OF 2,5-HEXANEDIONE.” Journal of Neuropathology and Experimental Neurology 47, no. 3 (May 1, 1988): 325–325.

Scholars@Duke

Pages